Mengkai Yang

651 total citations
17 papers, 484 citations indexed

About

Mengkai Yang is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Mengkai Yang has authored 17 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Surgery. Recurrent topics in Mengkai Yang's work include Cancer, Hypoxia, and Metabolism (2 papers), Protein Degradation and Inhibitors (2 papers) and Tendon Structure and Treatment (2 papers). Mengkai Yang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), Protein Degradation and Inhibitors (2 papers) and Tendon Structure and Treatment (2 papers). Mengkai Yang collaborates with scholars based in China and United States. Mengkai Yang's co-authors include Songsong Teng, Chengqing Yi, Zhuoying Wang, Yinxian Yu, Yingqi Hua, Zhengdong Cai, Kerun Niu, Qinghua Zhao, Zeze Fu and Sha Hua and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Applied Surface Science.

In The Last Decade

Mengkai Yang

16 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengkai Yang China 12 195 116 89 82 77 17 484
Ali Shokoohmand Australia 14 136 0.7× 183 1.6× 95 1.1× 66 0.8× 52 0.7× 18 505
Osama A. Elkashty Canada 13 173 0.9× 168 1.4× 46 0.5× 43 0.5× 79 1.0× 23 526
Yanru Wu China 16 271 1.4× 97 0.8× 76 0.9× 84 1.0× 90 1.2× 37 643
Idoia Gallego Spain 16 341 1.7× 177 1.5× 83 0.9× 47 0.6× 81 1.1× 39 734
Michael McCoy United States 13 160 0.8× 125 1.1× 124 1.4× 72 0.9× 50 0.6× 19 446
Feng Rao China 9 287 1.5× 90 0.8× 145 1.6× 64 0.8× 95 1.2× 9 542
Tomasz Trzeciak Poland 19 278 1.4× 170 1.5× 90 1.0× 86 1.0× 162 2.1× 47 851
Joana Vieira de Castro Portugal 16 247 1.3× 161 1.4× 127 1.4× 138 1.7× 60 0.8× 27 570
Tongmeng Jiang China 18 263 1.3× 274 2.4× 125 1.4× 82 1.0× 117 1.5× 28 850

Countries citing papers authored by Mengkai Yang

Since Specialization
Citations

This map shows the geographic impact of Mengkai Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengkai Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengkai Yang more than expected).

Fields of papers citing papers by Mengkai Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengkai Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengkai Yang. The network helps show where Mengkai Yang may publish in the future.

Co-authorship network of co-authors of Mengkai Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Mengkai Yang. A scholar is included among the top collaborators of Mengkai Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengkai Yang. Mengkai Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Yang, Mengkai, Weisong Zhao, He Zhang, et al.. (2025). Lnc-PHF3-3 aggravates the chemoresistance of osteosarcoma cells to doxorubicin via the miR-142-3p/HMGB1 axis. Translational Oncology. 53. 102328–102328.
2.
Cheng, Long, Mengkai Yang, Li Chen, et al.. (2025). Optimized synthesis and electrochemical behaviors of Prussian blue analogues cathodes for potassium-ion batteries. SHILAP Revista de lepidopterología. 5(2). 100331–100331. 1 indexed citations
3.
Yang, Mengkai, et al.. (2023). La–doped FeNiSe4/Fe0.8Ni0.2Se2/NF heterostructure for superior oxygen evolution reaction. Applied Surface Science. 627. 157313–157313. 6 indexed citations
4.
Li, Jingjie, Mengkai Yang, Zhuoying Wang, et al.. (2022). CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. Oncogene. 41(40). 4524–4536. 20 indexed citations
5.
Sun, Binbin, Chunfeng Zhao, Zhuoying Wang, et al.. (2021). Three-Dimensional Tendon Scaffold Loaded with TGF-β1 Gene Silencing Plasmid Prevents Tendon Adhesion and Promotes Tendon Repair. ACS Biomaterials Science & Engineering. 7(12). 5739–5748. 23 indexed citations
6.
Mu, Haoran, Kai Tian, Gangyang Wang, et al.. (2021). Personalized medicine modality based on patient-derived xenografts from a malignant transformed GCTB harboring H3F3A G34W mutation. Journal of Orthopaedic Translation. 29. 106–112. 9 indexed citations
7.
Jiang, Yafei, Gangyang Wang, Haoran Mu, et al.. (2021). Bromodomain Inhibition Attenuates the Progression and Sensitizes the Chemosensitivity of Osteosarcoma by Repressing GP130/STAT3 Signaling. Frontiers in Oncology. 11. 642134–642134. 14 indexed citations
8.
Yang, Mengkai, Ya Cao, Zhuoying Wang, et al.. (2021). Identification of two immune subtypes in osteosarcoma based on immune gene sets. International Immunopharmacology. 96. 107799–107799. 11 indexed citations
9.
Yu, Yinxian, Binbin Sun, Zhuoying Wang, et al.. (2021). Exosomes From M2 Macrophage Promote Peritendinous Fibrosis Posterior Tendon Injury via the MiR-15b-5p/FGF-1/7/9 Pathway by Delivery of circRNA-Ep400. Frontiers in Cell and Developmental Biology. 9. 595911–595911. 19 indexed citations
10.
Yang, Mengkai, Tao Zhang, Xiaojun Ma, et al.. (2021). MYLK4 promotes tumor progression through the activation of epidermal growth factor receptor signaling in osteosarcoma. Journal of Experimental & Clinical Cancer Research. 40(1). 166–166. 9 indexed citations
11.
Xu, Yiming, Weilin Sang, Yiming Zhong, et al.. (2021). CoCrMo‐Nanoparticles induced peri‐implant osteolysis by promoting osteoblast ferroptosis via regulating Nrf2‐ARE signalling pathway. Cell Proliferation. 54(12). e13142–e13142. 36 indexed citations
12.
Yang, Mengkai, Xiaojun Ma, Zhuoying Wang, et al.. (2021). Identification of a novel glycolysis-related gene signature for predicting the prognosis of osteosarcoma patients. Aging. 13(9). 12896–12918. 20 indexed citations
13.
Han, Jing, Jing Xu, Tao Zhang, et al.. (2020). Her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis. Cancer Letters. 496. 57–71. 28 indexed citations
14.
Wang, Zongyi, Fei Yin, Jing Xu, et al.. (2019). CYT997(Lexibulin) induces apoptosis and autophagy through the activation of mutually reinforced ER stress and ROS in osteosarcoma. Journal of Experimental & Clinical Cancer Research. 38(1). 44–44. 82 indexed citations
15.
Wang, Peilin, Songsong Teng, Chengyu Zhuang, et al.. (2019). Directed elimination of senescent cells attenuates development of osteoarthritis by inhibition of c-IAP and XIAP. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(10). 2618–2632. 31 indexed citations
16.
Yang, Mengkai, et al.. (2018). Ascorbic acid inhibits senescence in mesenchymal stem cells through ROS and AKT/mTOR signaling. Cytotechnology. 70(5). 1301–1313. 49 indexed citations
17.
Yu, Yinxian, Sha Hua, Mengkai Yang, et al.. (2016). Fabrication and characterization of electrospinning/3D printing bone tissue engineering scaffold. RSC Advances. 6(112). 110557–110565. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026